UnitedHealth Group (UNH) PT Lowered to $340 at Leerink Partners

Leerink Partners analyst Whit Mayo lowered the price target on UnitedHealth Group (NYSE: UNH) to $340.00 (from $355.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: Reiterate Outperform Rating. Buyside expectations have been moderately fading over the past month, ahead of the forthcoming reinstatement of UNH's 2025 guide. We think that $18 to $19 is generally the expectation, and anything in this zone should assuage fears given the materiality of the reduction in overall margins. That lays the preliminary groundwork to underwrite a multi-year margin story, with growth perhaps really re-accelerating in 2027 as UNH exits V28. Against a challenging and dynamic backdrop, we're cautiously optimistic on the positive thesis from here."

You May Also Be Interested In

• Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
• Stifel Canada Starts Cadillac Mines Corp (CADY:CN) at Buy
• Needham on Lululemon (LULU): 'Fundamentals Remain Challenged, We Remain Cautious'